ACAD
Acadia Pharmaceuticals·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
ACAD Filings
Filing Date
Form Description
Form Type
2025-11-19
Form 4 - Statement of changes in beneficial ownership of securities
Ownership
2025-11-19 · Ownership
Form 4 - Statement of changes in beneficial ownership of securities
2025-11-19
Form 4 - Statement of changes in beneficial ownership of securities
Ownership
2025-11-19 · Ownership
Form 4 - Statement of changes in beneficial ownership of securities
2025-11-14
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2025-11-14 ·
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2025-11-12
Form 4 - Statement of changes in beneficial ownership of securities
Ownership
2025-11-12 · Ownership
Form 4 - Statement of changes in beneficial ownership of securities
2025-11-10
Form 144 - Report of proposed sale of securities
Ownership
2025-11-10 · Ownership
Form 144 - Report of proposed sale of securities
2025-11-06
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Financials
2025-11-06 · Financials
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025-11-05
ACADIA Pharmaceuticals Inc. (ACAD) Q3 2025 Earnings Call Transcript
Earnings Call
2025-11-05 · Earnings Call
ACADIA Pharmaceuticals Inc. (ACAD) Q3 2025 Earnings Call Transcript
2025-11-05
Form 8-K - Current report
Key Events
2025-11-05 · Key Events
Form 8-K - Current report
2025-11-03
Form 8-K - Current report
Key Events
2025-11-03 · Key Events
Form 8-K - Current report
2025-09-16
Form 4 - Statement of changes in beneficial ownership of securities
Ownership
2025-09-16 · Ownership
Form 4 - Statement of changes in beneficial ownership of securities
